Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008–2009)

References

• Livermore DM. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs.2002;3:218–24.
   PubMedGoogle Scholar
• Goossens H, Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase and AmpC-producing Enterobacteriaceae from the MYSTIC program in Europe and the United States (1997–2004). Diagn Microbiol Infect Dis.2005;53:257–64.
   PubMed Web of Science ®Google Scholar
• Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, et al.. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002). Diagn Microbiol Infect Dis.2005;52:323–9.
   PubMed Web of Science ®Google Scholar
• Sader HS, Hsiung A, Fritsche TR, Jones RN. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype. Diagn Microbiol Infect Dis.2007;57:341–4.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Patel JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol.2008;29:1107–9.
   PubMed Web of Science ®Google Scholar
• Wong ES. The price of a surgical site infection: more than just excess length of stay. Infect Control Hosp Epidemiol.1999;20:722–4.
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother.2010;65:1119–24.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Canton R, Gniadkowski M. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother.2007;59:165–74.
   PubMed Web of Science ®Google Scholar
• Woodford N, Dallow, Hill RL. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents.2007;29:456–9.
   PubMed Web of Science ®Google Scholar
• Woodford N, Zhang J, Warner M. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother.2008;62:1261–4.
   PubMed Web of Science ®Google Scholar
• Hawser SP, Bouchillon SK, Hoban DJ, Badal RE. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005–2007: results from the SMART study. Int J Antimicrob Agents. 2009;34:585–8.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 7th ed. Document M7-A7. Wayne, PA: Clinical Laboratory Standards Institute (CLSI); 2008.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20th Informational Supplement. Document M100-S20. Wayne, PA: Clinical Laboratory Standards Institute (CLSI); 2010.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 20th Informational Supplement Update. Document M100-S20-U. Wayne, PA: Clinical Laboratory Standards Institute (CLSI); 2010.
   Google Scholar
• Mulvey MR, Bryce E, Boyd D, Agostini MO, Christianson S, Simor AE, et al.. Ambler class A extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother.2004;48:1204–4.
   PubMed Web of Science ®Google Scholar
• Nuesch-Inderbinen MT, Hachler H, Kayser FH. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis.1996;15:398–402.
   PubMed Web of Science ®Google Scholar
• Speldooren V, Heym B, Labia R, Nicolas-Chanoine MH. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob Agents Chemother.1998;424:879–84.
   Google Scholar
• Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al.. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother.2001;45:1151–61.
   PubMed Web of Science ®Google Scholar
• Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol.2002;40:2153–62.
   PubMed Web of Science ®Google Scholar
• Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al.. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother. In press 2011.
   Google Scholar
• Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother.2010;65:490–5.
   PubMed Web of Science ®Google Scholar
• Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al.. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother. 2006;58:205–10.
   PubMed Web of Science ®Google Scholar
• Hawser SP, Bouchillon SK, Hoban DJ, Badal RE. Epidemiologic trends, occurrence of extended-spectrum-beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002–2007 from the SMART study. Surg Infect.2010;11:371–8.
   PubMed Web of Science ®Google Scholar
• Pavez M, Neves P, Dropa M, Hatté MH, Gribaum RS, Elmor de Araújo MR, et al.. Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil. J Med Microbiol.2008;57:1590–2.
   PubMed Web of Science ®Google Scholar
• Mammeri H, Nordmann P, Berkani A, Eb F. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett.2008;282:238–40.
   PubMed Web of Science ®Google Scholar
• Lartigue MF, Poirel L, Poyart C, Réglier-Poupet H, Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis.2007;13:315–7.
   PubMed Web of Science ®Google Scholar